Display Settings:

Format

Send to:

Choose Destination
    Pharmacopsychiatry. 2003 Jun;36 Suppl 1:S32-7.

    Pharmacokinetics of Ginkgo biloba extracts.

    Source

    Research and Development, Dr. Willmar Schwabe GmbH & Co. KG, 76227 Karlsruhe, Germany. anton.biber@schwabe.de

    Abstract

    EGb 761 (definition see editorial) Ginkgo extract is produced by a validated production process. Its pharmacologically active constituents, flavonol glycosides and terpene lactones, are kept within a narrow range of 22 to 27 % and 5 to 7 %, respectively, by standardisation. The concentration of ginkgolic acids is below 5 ppm. The constant production process also maintains the concentrations of other constituents such as proanthocyanidins, carboxylic acids and non-flavone glycosides at a fairly constant level. In this article, we will summarise the data on the pharmacokinetics of flavonol glycosides and terpene lactones.

    PMID:
    13130386
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Georg Thieme Verlag Stuttgart, New York

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk